Showing 1371-1380 of 1513 results for "".
Diagnosing and Managing Hair Disorders
https://practicaldermatology.com/topics/general-topics/diagnosing-and-managing-hair-disorders/20624/From loss to overgrowth, hair disorders may be associated with systemic causes.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-10/23206/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20730/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20965/The Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/Turmeric, Curcumin, and Curcuminoids: A Dermatologic Review
https://practicaldermatology.com/columns/clinical-focus-1/turmeric-curcumin-and-curcuminoids-a-dermatologic-review/23377/Curcumin, one of the active compounds of turmeric, exhibits anti-inflammatory, antimicrobial, antioxidant, anti-nociceptive, and antineoplastic properties.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20477/